These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20799359)

  • 1. Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis.
    Head CA; Swerdlow P; McDade WA; Joshi RM; Ikuta T; Cooper ML; Eckman JR
    Am J Hematol; 2010 Oct; 85(10):800-2. PubMed ID: 20799359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.
    Gladwin MT; Kato GJ; Weiner D; Onyekwere OC; Dampier C; Hsu L; Hagar RW; Howard T; Nuss R; Okam MM; Tremonti CK; Berman B; Villella A; Krishnamurti L; Lanzkron S; Castro O; Gordeuk VR; Coles WA; Peters-Lawrence M; Nichols J; Hall MK; Hildesheim M; Blackwelder WC; Baldassarre J; Casella JF;
    JAMA; 2011 Mar; 305(9):893-902. PubMed ID: 21364138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.
    Weiner DL; Hibberd PL; Betit P; Cooper AB; Botelho CA; Brugnara C
    JAMA; 2003 Mar; 289(9):1136-42. PubMed ID: 12622584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation.
    Robieux IC; Kellner JD; Coppes MJ; Shaw D; Brown E; Good C; O'Brodovich H; Manson D; Olivieri NF; Zipursky A
    Pediatr Hematol Oncol; 1992; 9(4):317-26. PubMed ID: 1467165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
    Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
    Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.
    Dellinger RP; Zimmerman JL; Taylor RW; Straube RC; Hauser DL; Criner GJ; Davis K; Hyers TM; Papadakos P
    Crit Care Med; 1998 Jan; 26(1):15-23. PubMed ID: 9428538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of continuous co-infusion of morphine and naloxone in children with sickle cell pain crisis.
    Koch J; Manworren R; Clark L; Quinn CT; Buchanan GR; Rogers ZR
    Am J Hematol; 2008 Sep; 83(9):728-31. PubMed ID: 18543345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study.
    Maitre B; Djibre M; Katsahian S; Habibi A; Stankovic Stojanovic K; Khellaf M; Bourgeon I; Lionnet F; Charles-Nelson A; Brochard L; Lemaire F; Galacteros F; Brun-Buisson C; Fartoukh M; Mekontso Dessap A
    Intensive Care Med; 2015 Dec; 41(12):2121-9. PubMed ID: 26431718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
    Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
    J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.
    Taylor RW; Zimmerman JL; Dellinger RP; Straube RC; Criner GJ; Davis K; Kelly KM; Smith TC; Small RJ;
    JAMA; 2004 Apr; 291(13):1603-9. PubMed ID: 15069048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drepa-Opia: A Pilot Study to Determine the Predictive Factors of Morphine Use and Consumption in Hospitalized Adult Patients with Sickle Cell Disease.
    Sabrie M; Cannas G; Tazarourte K; Poutrel S; Connes P; Hot A; Renoux C; Fattoum J; Joly P
    Hemoglobin; 2018 Jul; 42(4):217-224. PubMed ID: 30604640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults.
    Bartolucci P; El Murr T; Roudot-Thoraval F; Habibi A; Santin A; Renaud B; Noël V; Michel M; Bachir D; Galactéros F; Godeau B
    Blood; 2009 Oct; 114(18):3742-7. PubMed ID: 19717646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breathing patterns during vaso-occlusive crisis of sickle cell disease.
    Needleman JP; Benjamin LJ; Sykes JA; Aldrich TK
    Chest; 2002 Jul; 122(1):43-6. PubMed ID: 12114337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is inhaled nitric oxide therapy more effective or safer than the conventional treatment for the treatment of vaso-occlusive crises in sickle-cell anemia?
    Moreira FT; de Oliveira CB; Gomez CM; Bernardo WM
    Rev Assoc Med Bras (1992); 2011; 57(3):253-4. PubMed ID: 21691684
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitric oxide metabolite levels in acute vaso-occlusive sickle-cell crisis.
    Lopez BL; Barnett J; Ballas SK; Christopher TA; Davis-Moon L; Ma X
    Acad Emerg Med; 1996 Dec; 3(12):1098-103. PubMed ID: 8959162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.